Monday, October 31, 2022

Spicing it up: Pro-drug curcumin shows clinical potential in mice

A prodrug form of curcumin, TBP1901, has shown anti-tumor effects without toxicities. The enzyme GUSB was identified for its key role in TBP1901 conversion to curcumin, which also has essential therapeutic targets.

from Top Health News -- ScienceDaily https://ift.tt/UAaGqMi
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Only 13 % know: The one-minute self-exam that could save young men’s lives

A new survey shows most Americans wrongly think testicular cancer is an older man's issue, despite it most commonly affecting men aged 2...